Treatment Needs Often Unmet for Generalized Pustular Psoriasis
Patients with flares more likely to have inpatient, emergency department visits
Psoriasis
Zoryve Cream Now Available for Plaque Psoriasis
Zoryve is supplied in a 60g tube containing 3mg (0.3%) of roflumilast per gram.
Citrate-Free Formulation of Taltz Now Available
The new formulation significantly reduced injection site pain compared with the original.
MPR Weekly Dose Podcast #125
A neurostimulation device has been cleared for post-C-section pain; a new plaque psoriasis treatment; the FDA addresses the contrast agent shortage; Lucentis biosimilar treatment is approved; and the recall is expanded for an over-the-counter laxative.
Zoryve Cream Approved for Plaque Psoriasis
The approval was based on data from the two phase 3 trials that included patients aged 12 years and older with mild to severe plaque psoriasis.
FDA to Review Biosimilar Hyrimoz High Concentration Formulation
The sBLA is supported by data from a phase 1 pharmacokinetics bridging study comparing Hyrimoz 50mg/mL and citrate-free Hyrimoz HCF.
Rise in Cost of Biologics for Psoriasis Outpacing Medical Inflation
Apart from secukinumab, the mean cost of biologics increased by >100 percent than inflation alone would explain
May 2022: Drug Pipeline Updates
Stay up-to-date on the latest drugs in development.
